SCHEMBL8570728

SCHEMBL8570728

O=c1[nH]c2c(CN3CCCc4ccccc43)cc(Br)c([N+](=O)[O-])c2[nH]c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.46
MEN1 O00255 8/20 0.46
ALDH1A1 P00352 7/20 0.46
KDM4E B2RXH2 6/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MAPT P10636 3/20 0.43
TSHR P16473 3/20 0.43
ALOX15 P16050 2/20 0.43
GAA P10253 2/20 0.43
MAPK1 P28482 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC2 Q92769 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL8092049 0.99 KMT2A (0.46) KMT2AMEN1ALDH1A1KDM4ENPSR1
Bromide SCHEMBL8087035 0.82 KDM4E (0.44) KMT2AMEN1ALDH1A1KDM4ENPSR1
SCHEMBL27462472 0.78 MAPK1 (0.43) KMT2AMEN1ALDH1A1KDM4ENPSR1
SCHEMBL8564844 0.68
SCHEMBL8568615 0.68 GRIN2D (0.40) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8085588 0.68 CYP1A2 (0.49) KMT2AMEN1GAALMNAPOLB
Bromide SCHEMBL8087219 0.67 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL8078882 0.67
SCHEMBL27445292 0.67 MAPK1 (0.44) KMT2AMEN1ALDH1A1KDM4ENPSR1
SCHEMBL31453137 0.66 TAAR1 (0.56) KMT2AMEN1ALDH1A1KDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1193968-A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives NOVARTIS AG (CH) 1998-09-23 CN claimed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP claimed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO claimed
CN-1197452-A Azetidinone derivatives for treatment of atherosclerosis SMITHKLINE BEECHAM PLC (GB) 1998-10-28 CN disclosed